Real ChatGPT answer · index seedtgKWfMQCW3EcompleteHealth and wellness · supplements and vitaminsinformational
Can you summarize recent clinical trials on niacin dosing protocols for managing high cholesterol when combined with a statin regimen?
Download run
Fan-out diagram
The searches the AI actually ran for this prompt.
SEED QUERY
Can you summarize recent clinical trials on niacin dosing protocols for managing high cholesterol when combined with a statin regimen?
3 real searches · 1 real-search pass
2024 2025 2026 clinical trials niacin statin combination dyslipidemia extended release niacin cardiovascular outcomes trial dosing protocolGoogle ↗
OBSERVED
AIM-HIGH HPS2-THRIVE niacin statin trial dose titration 1500 2000 mg protocol primary outcomes safetyGoogle ↗
OBSERVED
guidelines niacin add-on statin residual dyslipidemia not recommended 2024 2025Google ↗
OBSERVED
Badge and edge weight = share of passes that produced the query. Hover a query for its intent and routing format.
Query classes
Google's semantic query class for every sub-query: what kind of answer each search is after, simulated vs real.
Classifying 3 queries…
Searches and sources
ChatGPT3 real searches · gpt-6
2024 2025 2026 clinical trials niacin statin combination dyslipidemia extended release niacin cardiovascular outcomes trial dosing protocol Google ↗
AIM-HIGH HPS2-THRIVE niacin statin trial dose titration 1500 2000 mg protocol primary outcomes safety Google ↗
guidelines niacin add-on statin residual dyslipidemia not recommended 2024 2025 Google ↗
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · ahajournals.org
- 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines · ahajournals.org
- 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 · pmc.ncbi.nlm.nih.gov
- Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy · doi.org
- BioLINCC: Atherothrombosis Intervention in Metabolic Syndrome with Low HDL/High Triglyceride and Impact on Global Health Outcomes (AIM-HIGH) · biolincc.nhlbi.nih.gov
- HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment | European Heart Journal · academic.oup.com
- Serious Adverse Effects of Extended-release Niacin/Laropiprant: Results From the Heart Protection Study 2-Treatment of HDL to Reduce the Incidence of Vascular Events (HPS2-THRIVE) Trial · pubmed.ncbi.nlm.nih.gov
- These highlights do not include all the information needed to use NIACIN EXTENDED-RELEASE TABLETS safely and effectively. See full prescribing information for NIACIN EXTENDED-RELEASE TABLETS. NIACIN extended-release tablets USP, film coated, for oral useInitial U.S. Approval: 1997 · dailymed.nlm.nih.gov
- Niacin · ods.od.nih.gov
- Find publication · pubmed.ncbi.nlm.nih.gov
Queries
3 queries · click a column to sort
| Query / type | Search | Intent | Query class | Routing format | Cluster | Freq ↓ | Weight |
|---|---|---|---|---|---|---|---|
2024 2025 2026 clinical trials niacin statin combination dyslipidemia extended release niacin cardiovascular outcomes trial dosing protocol OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
AIM-HIGH HPS2-THRIVE niacin statin trial dose titration 1500 2000 mg protocol primary outcomes safety OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 | |
guidelines niacin add-on statin residual dyslipidemia not recommended 2024 2025 OBSERVED | Google ↗ AI Mode ↗ | — | — | — | — | 1x of 1 |